Skip to content

Common Stock at other companies

LivaNova logo
LivaNovaLIVN
$84.56M+0.1%
ICU Medical logo
ICU MedicalICUI
80M0.0%
United Therapeutics logo
United TherapeuticsUTHR
$800K0.0%
OSI Systems logo
OSI SystemsOSIS
$13.03M-34.3%

Other financials

Income statement

See full
Revenue$173.9M+21.2%
Gross profit$101.2M+14.7%
Operating income$13.3M-51.5%
Net income$7.3M-71.5%
EPS (diluted)$0.20-71.4%

Balance sheet

See full
Cash & equivalents$461.7M+48.9%
Total debt$409.9M+505%
Total equity$494.0M+85.5%
Total assets$1.4B+71.3%

Cash flow

See full
Operating cash flow$24.5M+959%
CapEx$36.7M+35.6%
Free cash flow-$12.1M+59.4%

Valuation

See full
Market cap$2.55B+50.6%
Enterprise value$2.5B+66.0%
P/E14.8×-19.8×
P/S+0.5×

Profitability

See full
Gross margin59.1%-0.4pp
Operating margin14.9%+4.1pp
Net margin27%+17.0pp
FCF margin23.8%

Returns & leverage

See full
Return on equity45.2%+22.2pp
Debt / equity0.8×+0.6×
Current ratio6.7×-2.4×

Where this comes from

Reported directly by TransMedics Group, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: TransMedics Group, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about TransMedics Group, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TransMedics Group, Inc.'s common stock?
TransMedics Group, Inc. (TMDX) reported common stock of $764.64M in Q1 2026.
How has TransMedics Group, Inc.'s common stock changed year-over-year?
TransMedics Group, Inc.'s common stock increased by 7.8% year-over-year, from $709.19M to $764.64M.
What is the long-term trend for TransMedics Group, Inc.'s common stock?
Over 5 years (2020 to 2025), TransMedics Group, Inc.'s common stock has grown at a 8.4% compound annual growth rate (CAGR), from $502.22M to $750.93M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).